ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q4 2020 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2021-02-16

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value: $115M (100.0% shares, 0.0% debt)

Holdings (2)

— MEDAVAIL HOLDINGS INC 51.0%

Value $58.48M Shares 3,885,951 Est. Cost $15.05 Unrealized —

LUNG PULMONX CORP 49.0%

Value $56.25M Shares 815,019 Est. Cost $48.97 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	3,885,951	$58.48M	51.0%	$15.05	—	COM	58406B103
LUNG	PULMONX CORP	815,019	$56.25M	49.0%	$48.97	0.0%	COM	745848101